John Perry’s practice is primarily focused on healthcare mergers and acquisitions and joint ventures, with a particular focus on diagnostic imaging, radiation therapy, urgent care, and ambulatory surgery centers. In addition, John performs healthcare due diligence in support of the firm’s representation of commercial lenders operating in the healthcare space. He helps his clients accomplish their business goals while navigating the fraud and abuse and other regulatory issues unique to healthcare transactions.
With a strong background of representing healthcare providers in operational matters, John’s experience includes physician employment and recruitment agreements, call coverage agreements, clinical co-management agreements, medical director agreements, telemedicine agreements, and other vendor/supplier agreements. He has also counseled healthcare systems regarding corporate and medical staff governance, credentialing and peer review, licensing and accreditation, reimbursement, and related compliance matters, as well as represented a broad range of providers in medical malpractice and licensure matters.
John’s varied interactions with healthcare bankers and investors, members of boards of directors, physician and non-physician executives, and front-line nurses and their managers have provided him with a broad understanding of the healthcare industry and the challenges faced at every level.
Recent closed healthcare transactions include:
In addition to healthcare, John’s experience includes trial and transactional work in corporate and securities matters, banking and financial services, and construction.
Ambulatory Surgery, Outpatient Imaging and Other Outpatient Services | Corporate and Securities | Healthcare | Healthcare Fraud and Abuse/Compliance | Healthcare Joint Ventures | Healthcare Mergers, Acquisitions, and Joint Ventures | Healthcare Restructuring | Hospitals and Health Systems | Medical Staff Issues | Nonprofit and Tax-exempt Issues | Private Companies | Private Equity | Regulatory Compliance
© Bradley Arant Boult Cummings LLP, 2021